Emerald Advisers LLC Buys New Shares in Plexus Corp. $PLXS

Emerald Advisers LLC bought a new position in shares of Plexus Corp. (NASDAQ:PLXS) during the first quarter, HoldingsChannel reports. The firm bought 166,532 shares of the technology company’s stock, valued at approximately $33,729,000. Plexus makes up approximately 1.1% of Emerald Advisers LLC’s investment portfolio, making the stock its 29th biggest position.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in PLXS. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in shares of Plexus by 6.0% during the 1st quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 1,858 shares of the technology company’s stock worth $376,000 after purchasing an additional 105 shares in the last quarter. Principal Financial Group Inc. raised its stake in shares of Plexus by 2.3% in the first quarter. Principal Financial Group Inc. now owns 153,392 shares of the technology company’s stock valued at $31,068,000 after purchasing an additional 3,477 shares in the last quarter. Fifth Third Bancorp lifted its position in Plexus by 6,710.3% in the first quarter. Fifth Third Bancorp now owns 13,825 shares of the technology company’s stock worth $2,800,000 after purchasing an additional 13,622 shares during the period. Sage Rhino Capital LLC bought a new position in Plexus in the first quarter worth $214,000. Finally, Abel Hall LLC lifted its position in Plexus by 51.4% in the first quarter. Abel Hall LLC now owns 2,321 shares of the technology company’s stock worth $470,000 after purchasing an additional 788 shares during the period. 94.45% of the stock is currently owned by institutional investors.

Plexus Stock Down 3.1%

Shares of NASDAQ:PLXS opened at $259.03 on Tuesday. Plexus Corp. has a 12 month low of $115.35 and a 12 month high of $307.06. The company’s 50-day moving average price is $275.87 and its two-hundred day moving average price is $224.53. The company has a quick ratio of 0.74, a current ratio of 1.54 and a debt-to-equity ratio of 0.06. The firm has a market cap of $6.93 billion, a P/E ratio of 37.87 and a beta of 0.88.

Plexus (NASDAQ:PLXS) last posted its quarterly earnings data on Wednesday, April 29th. The technology company reported $2.05 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.18. Plexus had a net margin of 4.35% and a return on equity of 12.84%. The firm had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.13 billion. During the same quarter last year, the company posted $1.66 EPS. The company’s quarterly revenue was up 18.7% compared to the same quarter last year. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. As a group, research analysts forecast that Plexus Corp. will post 5.98 EPS for the current fiscal year.

Insider Activity at Plexus

In related news, CEO Todd P. Kelsey sold 1,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 17th. The shares were sold at an average price of $294.98, for a total value of $442,470.00. Following the completion of the sale, the chief executive officer owned 68,888 shares of the company’s stock, valued at $20,320,582.24. This trade represents a 2.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Michael J. Running sold 510 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $272.17, for a total transaction of $138,806.70. Following the completion of the transaction, the insider owned 665 shares of the company’s stock, valued at $180,993.05. This trade represents a 43.40% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 21,981 shares of company stock valued at $5,855,318 over the last three months. 1.78% of the stock is owned by company insiders.

Analyst Ratings Changes

Several brokerages have issued reports on PLXS. Weiss Ratings raised shares of Plexus from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, July 6th. Wall Street Zen upgraded shares of Plexus from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Needham & Company LLC raised their price objective on shares of Plexus from $285.00 to $310.00 and gave the stock a “buy” rating in a report on Monday, June 1st. Benchmark reiterated a “buy” rating and set a $220.00 target price on shares of Plexus in a research report on Monday, March 16th. Finally, Stifel Nicolaus upped their target price on shares of Plexus from $280.00 to $330.00 and gave the company a “buy” rating in a research note on Monday, June 22nd. Five research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $246.67.

Plexus Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.